172 related articles for article (PubMed ID: 7792851)
1. Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy.
Mangiavacchi M; Frigerio M; Gronda E; Danzi GB; Bonacina E; Masciocco G; Olivia F; De Vita C; Pellegrini A
Transplant Proc; 1995 Jun; 27(3):1960-2. PubMed ID: 7792851
[No Abstract] [Full Text] [Related]
2. Does donor and recipient sex influence the development of cardiac allograft vasculopathy?
Mehra MR; Ventura HO; Escobar A; Cassidy CA; Smart FW; Stapleton DD
Transplant Proc; 1995 Jun; 27(3):1926-9. PubMed ID: 7792839
[No Abstract] [Full Text] [Related]
3. Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus infection.
Normann SJ; Salomon DR; Leelachaikul P; Khan SR; Staples ED; Alexander JA; Mayfield WR; Knauf DG; Sadler LA; Selman S
J Heart Lung Transplant; 1991; 10(5 Pt 1):674-87. PubMed ID: 1659903
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection and cardiac allograft vasculopathy in children.
Webber SA
Circulation; 2007 Apr; 115(13):1701-2. PubMed ID: 17404170
[No Abstract] [Full Text] [Related]
5. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
[TBL] [Abstract][Full Text] [Related]
6. Factors increasing the risk of allograft vascular disease in heart transplant recipients.
Arbustini E; Dal Bello B; Morbini P; Klersy C; Grasso M; Diegoli M; Gavazzi A; Campana C; Grossi P; Pellegrini C; Martinelli L; Ippoliti G; Specchia G; Viganò M
G Ital Cardiol; 1997 Oct; 27(10):985-99. PubMed ID: 9359048
[TBL] [Abstract][Full Text] [Related]
7. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
8. Short-term development of transplant-related coronary artery disease in orthotopic cardiac allograft recipients.
Albat B; Missov E; Serre I; Baldet P; Chaptal PA
Minerva Cardioangiol; 1995 Oct; 43(10):435-8. PubMed ID: 8819811
[TBL] [Abstract][Full Text] [Related]
9. Influence of HLA compatibility on the incidence of cardiac allograft vasculopathy after heart transplantation.
Stempfle HU; Mudra H; Strom C; Angermann CE; Klauss V; Rieber J; Scholz S; Spes C; Uberfuhr P; Theisen K
Transplant Proc; 1995 Jun; 27(3):1977-8. PubMed ID: 7792857
[No Abstract] [Full Text] [Related]
10. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy.
Everett JP; Hershberger RE; Norman DJ; Chou S; Ratkovec RM; Cobanoglu A; Ott GY; Hosenpud JD
J Heart Lung Transplant; 1992; 11(3 Pt 2):S133-7. PubMed ID: 1320405
[TBL] [Abstract][Full Text] [Related]
11. Experimental cardiac allograft vasculopathy in mice.
Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
[TBL] [Abstract][Full Text] [Related]
12. Some prognostic factors for the development of transplant-related coronary artery disease in human cardiac allografts.
Stovin PG; Sharples L; Hutter JA; Wallwork J; English TA
J Heart Lung Transplant; 1991; 10(1 Pt 1):38-44. PubMed ID: 1848788
[TBL] [Abstract][Full Text] [Related]
13. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
14. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
[TBL] [Abstract][Full Text] [Related]
15. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation.
Baan CC; Holweg CT; Niesters HG; van Gelder T; Mol WM; Zondervan PE; Mochtar B; Balk AH; Weimar W
J Heart Lung Transplant; 1998 Apr; 17(4):363-73. PubMed ID: 9588581
[TBL] [Abstract][Full Text] [Related]
16. [Cytomegalovirus arteriolitis: gangrene of the feet and early coronary disease after heart transplantation].
Loire R; Bastien O; Tabib A; Vigneron M
Arch Mal Coeur Vaiss; 1993 Feb; 86(2):255-8. PubMed ID: 8395793
[TBL] [Abstract][Full Text] [Related]
17. Cardiac allograft vasculopathy: current concepts.
Ventura HO; Smart FW; Stapleton DD; Toups T; Price HL
J La State Med Soc; 1993 May; 145(5):195-8, 200-2. PubMed ID: 8393471
[TBL] [Abstract][Full Text] [Related]
18. [Coronary disease of transplanted heart. Physiopathology, prevention].
Heim M; Nicolino-Peltier C; Metras D; Habib G; Kretmann B; Luccioni R; Bertault-Perez P
Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():185-8. PubMed ID: 1337427
[TBL] [Abstract][Full Text] [Related]
19. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
